Does RISANKIZUMAB-RZAA Cause Cystitis? 113 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 113 reports of Cystitis have been filed in association with RISANKIZUMAB-RZAA. This represents 0.2% of all adverse event reports for RISANKIZUMAB-RZAA.
113
Reports of Cystitis with RISANKIZUMAB-RZAA
0.2%
of all RISANKIZUMAB-RZAA reports
1
Deaths
61
Hospitalizations
How Dangerous Is Cystitis From RISANKIZUMAB-RZAA?
Of the 113 reports, 1 (0.9%) resulted in death, 61 (54.0%) required hospitalization.
Is Cystitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 113 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Cystitis?
ADALIMUMAB (1,267)
METHOTREXATE (996)
ETANERCEPT (926)
PREDNISONE (746)
TOFACITINIB (713)
RITUXIMAB (712)
DENOSUMAB (635)
OCRELIZUMAB (628)
SECUKINUMAB (613)
LENALIDOMIDE (547)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Cystitis Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA